Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Mexico begins rocky rollout of COVID-19 vaccinations for elderly

Published 02/15/2021, 06:36 PM
Updated 02/15/2021, 06:41 PM
© Reuters. COVID-19 vaccination in Mexico City

By Carlos Jasso

MEXICO CITY (Reuters) - Mexico on Monday began the task of vaccinating millions of senior citizens against the coronavirus, with dozens of Mexicans over 60 years old waiting in line for hours because of delays in administering shots.

Mexico began vaccinating healthcare workers in late December, and is starting a second phase for the elderly, even as it waits for more vaccine shipments.

By the end of April, the government aims to have inoculated everyone over 60, or 12% of the population of about 128 million, who are among the most vulnerable to complications from COVID-19, the disease caused by the virus.

But the rollout began slowly in Mexico City. By midday, 75-year-old Elena Diaz had already waited in the sun for three hours and counting for her shot.

Standing outside a public hospital, she said friends and relatives had died from the virus, and she was worried about her exposure to other people in the line.

"I'm very scared of getting infected," she said. "I've taken my paracetamol and tea to look after myself. God willing, nothing has happened to me and nothing will."

Many across the city came with canes, stools and folding chairs. Others arrived in wheelchairs.

Mexico City Mayor Claudia Sheinbaum apologized for the delays. Some sites did not receive the vaccine until three hours after lines began forming at 8 a.m., the mayor said. By mid-afternoon, the city had given shots to 10,565 people.

Sheinbaum told reporters the government was working to speed up registrations and provide more chairs to people waiting, after complaints that some had nowhere to sit.

© Reuters. COVID-19 vaccination in Mexico City

A 67-year-old woman was the only person to suffer an allergic reaction to the vaccine; she was now in stable condition in hospital, Sheinbaum said. Another person fainted while in line and was given a wheelchair, she added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.